Nevertheless, administration with FLT, FBT, or orlistat for eight weeks significantly suppressed the liver’s TNF-α, IL-1β, and IL-6 expression levels (p < 0.05), thus alleviating the inflammation induced by obesity. This evidence concerns the gene IL1B and obesity disorder.